Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients
Figure 2
Kaplan-Meier analysis of the incidence of grade 3 peripheral neuropathy with respect to the dose of cumulative oxaliplatin in the GJG and non-GJG groups.